Issue of Equity
The Company incurred expenses in connection with the Subscription of
As a result, the Company has issued a total of 40,514,880 new ordinary shares and application will be made for them to be admitted to trading on AQSE, which is expected to be on or around
The new ordinary shares will rank pari passu with the existing ordinary shares of the Company. Following the issue of the new ordinary shares, the Company's issued share capital will comprise 938,374,784 ordinary shares of 0.1p (including the 40,514,880 new ordinary shares).
The above figure of 938,374,784 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
This announcement contains information which, prior to its disclosure, was inside information for the purposes of Article 7 of EU Regulation 596/2014.
The directors of
Tel: +44 (0)7830 182501
AQSE Corporate Adviser
Tel: +44 (0)207 399 9400
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the